Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/33039
Title: Evaluating the Effectiveness of a Novel Skin Barrier Protectant in a Patient with Acute Radiodermatitis of the Vulva: A Case Report
Authors: Van Bever, Leen
Claes, Stefan
ROBIJNS, Jolien 
Censabella, Sandrine
Pannekoeke, Luc
Van de Werf, Evelyn
BULENS, Paul 
Issue Date: 2020
Publisher: 
Source: Advances in Skin & Wound Care, 34 (1) , p. 49 -55
Abstract: Objective To evaluate the use of Cavilon Advanced Skin Protectant in a patient treated with radiotherapy for vulvar cancer. Design Case report study Setting Radiotherapy department Participants Two female patients undergoing radiotherapy for vulvar carcinoma. Interventions In this case report study a novel skin barrier protectant, Cavilon Advanced Skin Protectant, was evaluated in a patient treated with vulvar radiodermatitis. Besides, another patient with vulvar radiodermatitis undergoing the institutional standard skin care protocol was portrayed. Main Outcome Measures Patient's skin reactions were evaluated by using the Radiotherapy Oncology Group Criteria by a radiotherapy nurse, alongside the patient's pain.
Keywords: case report;radiation dermatitis;radiotherapy;skin barrier protectant;toxicity;vulvar carcinoma
Document URI: http://hdl.handle.net/1942/33039
ISSN: 1527-7941
e-ISSN: 1538-8654
DOI: 10.1097/01.ASW.0000722768.95461.82
ISI #: 000600760600009
Rights: 2020 Wolters Kluwer Health, Inc. All rights reserved.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
MainTextfile_casereport_270120_adv.pdfPeer-reviewed author version183.27 kBAdobe PDFView/Open
VanBever_2021_CaseReport_Cavilon.pdf
  Restricted Access
Published version1.7 MBAdobe PDFView/Open    Request a copy
Show full item record

Page view(s)

14,254
checked on May 27, 2022

Download(s)

372
checked on May 27, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.